Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF‐36
Authors:
Abstract
Background: With interest in health economics growing, it is important to know whether utilities may be used to measure health‐related quality of life in patients with rhinoconjunctivitis. The objective was to compare the validity and measurement properties of disease‐specific versions of the standard gamble and rating scale with those of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) and the Short‐Form 36 (SF‐36). Methods: One hundred adults with symptomatic rhinoconjunctivitis participated in a 5 week observational study, completing the standard gamble, rating scale, RQLQ and SF‐36 at baseline and after 1 and 5 weeks. Symptom diaries were completed for 1 week before each follow‐up visit. Results: Reliability was highest for the RQLQ (intraclass correlation coefficient = 0.97), followed by the rating scale (0.75), the SF‐36 physical (0.75), the SF‐36 mental (0.74) and the standard gamble (0.12). The responsiveness index was highest for the RQLQ (0.76), followed by the rating scale (0.56) and the SF‐36 mental (0.28). Both cross‐sectional and longitudinal validity were strongest for the RQLQ and the rating scale. Conclusions Both the rating scale and the RQLQ have strong evaluative and discriminative properties. The SF‐36 has acceptable discriminative properties but its evaluative properties are poor. All measurement properties for the standard gamble are inadequate. Poor correlation between the standard gamble and the rating scale indicates that utilities cannot be derived from rating scale data.Keywords
This publication has 19 references indexed in Scilit:
- A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task forceAllergy, 2001
- Interpretation of rhinoconjunctivitis quality of life questionnaire dataJournal of Allergy and Clinical Immunology, 1996
- The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitisJournal of Allergy and Clinical Immunology, 1996
- Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaireJournal of Allergy and Clinical Immunology, 1996
- Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status QuestionnaireJournal of Allergy and Clinical Immunology, 1994
- Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitisClinical & Experimental Allergy, 1991
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- The MOS Short-form General Health SurveyMedical Care, 1988
- Measuring change over time: Assessing the usefulness of evaluative instrumentsJournal of Chronic Diseases, 1987
- Utility approach to measuring health-related quality of lifeJournal of Chronic Diseases, 1987